Sports and exercise do not only make people feel fit, they also decrease the likelihood of various illnesses (including chronic illnesses) and psychological disorders. The Netherlands Organisation for Health Research and Development (ZonMw) conducts research and recommends interventions to promote healthier lifestyles and improve the performance of athletes of all levels. ZonMw also encourages and facilitates innovations, helps to reduce the occurrence of sports injuries, and encourages participation in sports and exercise activities. Our ultimate objective is for everybody to be able to profit from sports and exercise, both socially and economically.
ZonMw funds hundreds of sports and exercise projects.
Can make all the difference to high-level sporting performance, wider participation in sport, and the development of a healthy, active lifestyle. Through programming, funding research, stimulating and facilitating innovation, and promoting participation in sport and exercise, ZonMw is contributing to a growing body of knowledge on the benefits of sport and movement.
ZonMw strives to bring about societal and economic returns on sport and exercise; the results include healthier lifestyles, better sporting performances, fewer injuries, and a growing recognition of the importance of sport and exercise in social issues.
In the Netherlands, sport policy is carried out both on a national and on a local level. The government encourages the development of elite sport and community sport through programs aimed at increasing knowledge and innovation and encouraging sport participation.
GloPID-R is pleased to welcome the Netherlands Organisation for Health Research and Development (ZonMw), represented by Suzanne Verver, into the network. GloPID-R is a unique international network of major research funding organizations. The network of 27 countries facilitates a rapid and effective research response to infectious disease outbreaks.
KNAW (Royal Netherlands Academy of Arts and Sciences), NWO (Netherlands Organisation for Scientific Research) and ZonMw (Netherlands Organisation for Health Research and Development) will sign the San Francisco Declaration on Research Assessment (DORA) on 18 April.
On April 1st 2019 the kick-off meeting of the European public-private partnership VALUE-Dx took place. This European-wide approach aims to generate evidence on the medical, economic, and public health value of diagnostics in tackling antimicrobial resistance (AMR). As a member of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), ZonMw participates in this consortium.
17 researchers who have recently received their PhDs can do their research at foreign research institutes thanks to a Rubicon grant from NWO. They will investigate, amongst other things, artificial intelligence for improved ultrasonography, Imaging muscle function in ALS patients, Printing living tissue through protective cell coating and new blood vessel formation.
While the pharmaceutical, medical technologies, chemical, cosmetics and food industries are increasingly seeking solutions to improve for example their prediction of clinical efficacy and/or risk and safety assessments without the use of animals, the solutions are still insufficient;
Societal demand for animal-free testing is increasing and there is a need for new innovations to improve human health, a stimulation of this research field is therefore needed;